Cobalt, Serum or Plasma
Ordering Recommendation
May be used in the assessment of occupational exposure or toxic ingestion.
New York DOH Approval Status
Specimen Required
Diet, medication, and nutritional supplements may introduce interfering substances. Patients should be encouraged to discontinue nutritional supplements, vitamins, minerals, and nonessential over-the-counter medications (upon the advice of their physician).
Royal blue (no additive), royal blue (K2EDTA), or royal blue (NaHep).
Separate from cells ASAP or within 2 hours of collection. Transfer 2 mL serum or plasma to an ARUP Trace Element-Free Transport Tube (ARUP supply #43116) available online through eSupply using ARUP Connect™ or contact ARUP Client Services at 800-522-2787 (Min: 0.5 mL). Do not use utensils (i.e., syringes, needles) during the transfer of the sample. Carefully pour directly into the transport tube avoiding transfer of the cellular components of blood.
Room temperature. Also acceptable: Refrigerated or frozen.
Specimens collected in containers other than specified. Specimens transported in containers other than specified.
Ambient: Indefinitely; Refrigerated: Indefinitely; Frozen: Indefinitely
Methodology
Quantitative Inductively Coupled Plasma-Mass Spectrometry
Performed
Sun-Sat
Reported
1-3 days
Reference Interval
Less than or equal to 1.0 µg/L
Interpretive Data
Elevated results may be due to skin or collection-related contamination, including the use of a noncertified metal-free collection/transport tube. If contamination concerns exist due to elevated levels of serum/plasma cobalt, confirmation with a second specimen collected in a certified metal-free tube is recommended.
Serum cobalt levels can be used in the assessment of occupational exposure or toxic ingestion. Symptoms associated with cobalt toxicity vary based on route of exposure, and may include cardiomyopathy, allergic dermatitis, pulmonary fibrosis, cough, and dyspnea.
Serum cobalt levels can be significantly higher in patients with metal-on-metal total hip replacement implants than in control patients without metal implants. Serum cobalt levels may be increased in asymptomatic patients with metal-on-metal prosthetics and should be considered in the context of the overall clinical scenario. Whole blood is the specimen type recommended by the U.S. Food and Drug Administration for assessing the risks of metal-on-metal hip implants in symptomatic patients.
Laboratory Developed Test (LDT)
Note
Hotline History
Hotline History
CPT Codes
83018
Components
Component Test Code* | Component Chart Name | LOINC |
---|---|---|
0025037 | Cobalt, Serum or Plasma | 5627-5 |
Aliases
- COS
- Co
- Plasma cobalt level